Education

MOGLYNET project
The Horizon 2020 MSCA joint doctoral project MOGLYNET (“Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study”) aims to define a new joint PhD educational model in Drug Discovery and Development and to promote institutional cooperation and mobility. The programme is run by a Consortium of Universities in cooperation with Industries and Associations operating in the Pharma sector with the aim to offer an innovative PhD level training in Drug Discovery and Development to 12 Early Stage Researchers. An active contribution of Industry in training activities is an important feature of the programme. The research methodologies and approaches proposed by the MOGLYNET consortium are strongly multidisciplinary and will involve a number of different state-of-the-art technologies and methodologies – computational chemistry, chemical synthesis, bioanalytics and biophysics, in vitro biological evaluation, in vivo studies, imaging, metabolomics, proteomics and oxidative stress.

EIPG is a partner in this important project and will be involved in the recruitment phase of students for this project and in the assistance for setting up appropriate training courses promoting an integrated knowledge between university research and pharmaceutical industrial expectations. Anni Svala, EIPG Vice-President Education and Careers and Finnish delegate, is in charge of representing EIPG in this project. 

The MOGLYNET project brochure is available online for further information on the project.

MOGLYNET Publications
  • MOGLYNET – Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study – H2020. Impact 2017, 8, 26

EIPG Affiliation for Professional Development
EIPG has always firmly believed in the value of continuing development in ensuring that industrial pharmacists fulfil their roles at the highest level of professionalism within the pharmaceutical industry. Prof. Luigi Martini, Past President of EIPG, and John Jolley, a delegate for many years to the General Assembly for the Royal Pharmaceutical Society of Great Britain, are currently members of the Board of Directors of Pharma Consult Global Ltd., a provider of online training courses worldwide. Ever committed to European industrial pharmacists, they have intervened to establish an affiliation between EIPG and Pharma Consult Global Ltd., through which short courses and webinars are being made available to members of EIPG Member national professional organisations, as discussed during the General Assembly in 2014 in Sofia. The courses have been specifically prepared to help in the implementation of new regulations and regulatory guidelines and as new regulatory issues arise, new e-learning courses and accompanying webinars will be introduced. All e -learning courses contain a video of the published material , essential reading material and delegate assessment. Certificates will be provided upon successful completion of the course. Initially the courses will be in the English language but Spanish translation is planned for the near future. Interested individuals should access the Pharma Consult Global website through the indicated hyperlink for further information. 

PHAR-IN project
The PHAR-IN consortium (538252-LLP-1-2013-1-BE-ERASMUS-EKA) consists of pharmacy faculties and industrial partners from countries of the European Higher Education Area (EHEA), members of the European Association of Faculties of Pharmacy (EAFP), together with the European Industrial Pharmacists’ Group (EIPG). PHAR-IN is funded by the European Commission via its Education, Audio-visual and Culture Agency (EACEA).

The aim of the project is to recruit a panel of industrialists and educationalists that will propose a list of competences and outcomes required for education in biotechnology for future and current employees in the pharmaceutical industry. These will then be ranked using Delphi methodology in importance by a wider panel of industrialists and academics (drawn in a first stage from EIPG and EAFP membership with a snowballing effect for recruitment of others). Using several rounds of the Delphi process, a consensual, hierarchal list of competences and outcomes will be produced and possible factoid competences removed. The list will then be used to adapt the education and training in biotechnology given at HEIs.

PHAR-IN Publications

PHARMINE project
The PHARMINE consortium consists of four universities (Brussels, Nancy, London and Lisbon) that are members of the European Association of Faculties of Pharmacy and EU partner associations representing community (Pharmaceutical Group of the European Union), hospital (European Association of Hospital Pharmacists) and industrial (European Industrial Pharmacists Group) pharmacy, together with the European Pharmacy Students’ Association and other interested bodies. It will develop a bachelor/master/doctorate system for pharmacy education and training taking into account the need for basic pharmaceutical competences (and mutual recognition of pharmacy qualifications) and the specialization needed in the three main areas of pharmaceutical expertise.

To do this the consortium will survey existing EU pharmacy curricula and attempts to adapt these to the Bologna process. The consortium will then produce a common competency curriculum as well as curricula for specialized pharmacy practice. This will be presented to the EU commission, national authorities and national professional pharmacy bodies. The aim is to put forward an EU standard for pharmacy education and training to be adopted by both the older and newer member states as well as candidates for EU membership and countries in non-EU areas such as Africa, China, India and South America. EAFP will provide advice, quality assurance and approval to countries and higher education institutions wishing to adopt this new EU standard for pharmacy education and training.

The PHARMINE project has been funded with support from the European Commission, Lifelong Learning Programme of the European Union.

PHARMINE Publications